Raymond Evers
Impact in
- Oncology top 0.2%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Pharmacology 36
- Pharmacogenetics and Drug Metabolism 32
- Drug-Induced Hepatotoxicity and Protection 8
- Oncology 65
- Drug Transport and Resistance Mechanisms 64
- Co-authors
- Piet Borst (19 shared papers)Marcel Kool (5 shared papers)Jan Wijnholds (4 shared papers)Xiaoyan Chu (28 shared papers)Liesbeth van Deemter (5 shared papers)Kelly Bleasby (8 shared papers)Ronald P.J. Oude Elferink (4 shared papers)Balázs Sarkadi (5 shared papers)
- Journals
- Drug Metabolism and Disposition (17 papers)Clinical Pharmacology & Therapeutics (10 papers)Nucleic Acids Research (6 papers)Molecular Pharmacology (5 papers)The EMBO Journal (5 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Raymond Evers
108 papers receiving 12.6k citations
Raymond Evers's Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 8.2k
- Pharmacology 2.5k
- Pediatrics, Perinatology and Child Health 3.8k
- Biochemistry 768
- Infectious Diseases 1.3k
Countries citing papers authored by Raymond Evers
This map shows the geographic impact of Raymond Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Evers more than expected).
Fields of papers citing papers by Raymond Evers
This network shows the impact of papers produced by Raymond Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Evers. The network helps show where Raymond Evers may publish in the future.
Co-authors
The 25 scholars most cited alongside Raymond Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Membrane transporters in drug development Hit paper breakdown → | 2010 | 2751 |
| 2 | A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins Hit paper breakdown → | 2000 | 1485 |
| 3 | The multidrug resistance protein family Hit paper breakdown → | 1999 | 553 |
| 4 | 1998 | 551 | |
| 5 | 1997 | 382 | |
| 6 | 2000 | 289 | |
| 7 | 1998 | 289 | |
| 8 | 2012 | 259 | |
| 9 | 1996 | 238 | |
| 10 | 2006 | 232 | |
| 11 | 1987 | 224 | |
| 12 | 1999 | 222 | |
| 13 | 2013 | 215 | |
| 14 | 2000 | 197 | |
| 15 | 2000 | 192 | |
| 16 | 2013 | 167 | |
| 17 | 1996 | 155 | |
| 18 | 2014 | 154 | |
| 19 | 2014 | 154 | |
| 20 | 2007 | 150 |
About Raymond Evers
Raymond Evers is a scholar working on Pharmacology, Oncology, Pediatrics, Perinatology and Child Health, Epidemiology and Biochemistry, having authored 111 papers that have together received 13.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (64 papers), Pharmacological Effects and Toxicity Studies (41 papers), Pharmacogenetics and Drug Metabolism (32 papers), HIV/AIDS drug development and treatment (10 papers), Trypanosoma species research and implications (9 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Amino Acid Enzymes and Metabolism (8 papers) and Pediatric Hepatobiliary Diseases and Treatments (7 papers). The work is most often cited by research in Oncology (8.2k citations), Pharmacology (2.5k citations), Pediatrics, Perinatology and Child Health (3.8k citations), Biochemistry (768 citations) and Infectious Diseases (1.3k citations). Raymond Evers has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Piet Borst, Marcel Kool, Jan Wijnholds, Xiaoyan Chu, Liesbeth van Deemter, Kelly Bleasby, Ronald P.J. Oude Elferink, Balázs Sarkadi, Éva Bakos and Alfred H. Schinkel. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Nucleic Acids Research, Molecular Pharmacology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.